High Prevalence of PER-1 Extended-Spectrum β-Lactamase-Producing Acinetobacter spp. in Korea
Open Access
- 1 May 2003
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (5) , 1749-1751
- https://doi.org/10.1128/aac.47.5.1749-1751.2003
Abstract
PER-1, an extended-spectrum β-lactamase, has been reported only in Europe. We detected PER-1 in 53 of 97 acinetobacters in Korea, mainly in the sputum of intensive care unit patients. Pulsed-field gel electrophoresis analysis suggested that clonal spread had occurred. Only PCR reliably detected PER-1 producers. PER-1 producers may also exist in other Asian countries.Keywords
This publication has 12 references indexed in Scilit:
- bla VIM-2 Cassette-Containing Novel Integrons in Metallo-β-Lactamase-Producing Pseudomonas aeruginosa and Pseudomonas putida Isolates Disseminated in a Korean HospitalAntimicrobial Agents and Chemotherapy, 2002
- Clinical importance of extended-spectrum β-lactamase (PER-1-type)-producing Acinetobacter spp. and Pseudomonas aeruginosa strainsJournal of Medical Microbiology, 2001
- Dynamics of a Nosocomial Outbreak of Multidrug-Resistant Pseudomonas aeruginosa Producing the PER-1 Extended-Spectrum β-LactamaseJournal of Clinical Microbiology, 2001
- Extended-spectrum beta-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in France.1999
- Extended-spectrum β-lactamase-producing strain of Acinetobacter baumannii isolated from a patient in FranceJournal of Antimicrobial Chemotherapy, 1999
- Widespread detection of PER-1-type extended-spectrum beta-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter studyAntimicrobial Agents and Chemotherapy, 1997
- Resistance to extended-spectrum cephalosporins, caused by PER-1 -lactamase, in M Salmonella typhimurium from Istanbul, TurkeyJournal of Medical Microbiology, 1995
- Sequence analysis of PER-1 extended-spectrum beta-lactamase from Pseudomonas aeruginosa and comparison with class A beta-lactamasesAntimicrobial Agents and Chemotherapy, 1994
- In-vitro activities of cefepime against Enterobacter cloacae, Serratia marcescens, Pseudomonas aeruginosa and other aerobic Gram-negative bacilliJournal of Antimicrobial Chemotherapy, 1993
- Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1993